Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine-induced oxidative stress

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1763, Issue 9, 2006, Pages 977-989

  Nakamura, Megumi ^a   Yamada, Masaki ^b   Ohsawa, Takako ^a   Morisawa, Hiraku ^a   Nishine, Tsutomu ^b   Nishimura, Osamu ^b,c   Toda, Tosifusa ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b SHIMADZU CORPORATION   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

6 hydroxydopamine; Oxidative stress; Phosphoproteome; SH SY5Y cells

Indexed keywords

CELL PROTEIN; DOPAMINE; DYE; ELONGATION FACTOR 2; GLUTATHIONE TRANSFERASE P1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; LAMIN A; LAMIN C; NEUROTOXIN; OXIDOPAMINE; PHOSPHOPROTEIN; PROTEOME; REACTIVE OXYGEN METABOLITE; T COMPLEX PROTEIN 1 EPSILON; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOPAMINERGIC NERVE CELL; ENZYME ASSAY; GEL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; STRESS RESPONSE ELEMENT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; OXIDATIVE STRESS; OXIDOPAMINE; PHOSPHOPROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33748292812     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.07.008     Document Type: Article

References (41)

1. Butterfield D.A., and Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122 (2001) 945-962
2. Maccioni R.B., Munoz J.P., and Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch. Med. Res. 32 (2001) 367-381
3. Perry T.L., Godin D.V., and Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency?. Neurosci. Lett. 33 (1982) 305-310
4. Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., and Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10 (2006) 389-406
5. Toda T., Morimasa T., Kobayashi S., Nomura K., Hatozaki T., and Hirota M. Proteomic approach to determination of the significance of protein oxidation in the ageing of mouse hippocampus. Appl. Genomics Proteomics 2 (2003) 43-50
6. Huhmer A.F., Gerber N.C., de Montellano P.R., and Schoneich C. Peroxynitrite reduction of calmodulin stimulation of neuronal nitric oxide synthase. Chem. Res. Toxicol. 9 (1996) 484-491
7. Richards E.M., Rosenthal R.E., Kristian T., and Fiskum G. Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity. Free Radical Biol. Med. 40 (2006) 1960-1970
8. Biedler J.L., Helson L., and Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33 (1973) 2643-2652
9. Biedler J.L., Roffler-Tarlov S., Schachner M., and Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38 (1978) 3751-3757
10. Kumar R., Agarwal A.K., and Seth P.K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64 (1995) 1703-1707
11. Storch A., Kaftan A., Burkhardt K., and Schwarz J. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism. J. Neural Transm. 107 (2000) 281-293
12. Kienzl E., Puchinger L., Jellinger K., Linert W., Stachelberger H., and Jameson R.F. The role of the transition metals in the pathogenesis of Parkinson's disease. J. Neurol. Sci. 134 (1995) 69-78 (Suppl.)
13. Andrew R., Watson D.G., Best S.A., Midgey H., Wenlong H., and Petty R.K.H. The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls. Neurochem. Res. 18 (1993) 1175-1177
14. Kostrzewa R.M., and Jacobowitz D.M. Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 26 (1974) 199-288
15. Glinka Y., Gassen M., and Youdin M.B.H. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm., Suppl. 50 (1997) 55-66
16. Choi W.S., Yoon S.Y., Oh T.H., Choi E.J., O'Malley K.L., and Oh Y.J. Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J. Neurosci. Res. 57 (1999) 86-94
17. von Coelln R., Kügler S., Bähr M., Weller M., Dichgans J., and Schulz J.B. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77 (2001) 263-273
18. Lee Y.M., Park S.H., Chung K.C., and Oh Y.J. Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine. Neurosci. Lett. 352 (2003) 17-20
19. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
20. Schulenberg B., Aggeler R., Beechem J.M., Capaldi R.A., and Patton W.F. Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J. Biol. Chem. 278 (2003) 27251-27255
21. Toda T. Proteomic analysis of phosphorylated proteins. Mol. Med. 41 (2004) 530-537
22. Stasyk T., Morandell S., Bakry R., Feuerstein I., Huck C.W., Stecher G., Bonn G.K., and Huber L.A. Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining. Electrophoresis 26 (2005) 2850-2854
23. Gorg A., Postel W., Baumer M., and Weiss W. Two-dimensional polyacrylamide gel electrophoresis, with immobilized pH gradients in the first dimension, of barley seed proteins: discrimination of cultivars with different malting grades. Electrophoresis 13 (1992) 192-203
24. Toda T., and Kimura N. Standardization of protocol for Immobiline 2-D PAGE and construction of 2-D PAGE protein database on World Wide Web home page. Jpn. J. Electrophor. 41 (1997) 13-19
25. Kuyama H., Toda C., Watanabe M., Tanaka K., and Nishimura O. An efficient chemical method for dephosphorylation of phosphopeptides. Rapid Commun. Mass Spectrom. 17 (2003) 1493-1496
26. Hayes J.D., and McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radical Res. 31 (1999) 273-300
27. Huang J., Tan P.H., Tan B.K., and Bay B.H. GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol. Rep. 12 (2004) 921-925
28. Ishisaki A., Hayashi H., Suzuki S., Ozawa K., Mizukoshi E., Miyakawa K., Suzuki M., and Imamura T. Glutathione S-transferase Pi is a dopamine-inducible suppressor of dopamine-induced apoptosis in PC12 cells. J. Neurochem. 77 (2001) 1362-1371
29. Bello M., Nuccetelli M., Caccuri A.M., Stella L., Parker M.W., Rossjohn J., McKinstry W.J., Mozzi A.F., Federici G., Polizio F., Pedersen J.Z., and Riccia G. Human glutathione transferase P1-1 and nitric oxide carriers. A new role for an old enzyme. J. Biol. Chem. 276 (2001) 42138-42145
30. Maria F.D., Pedersen J.Z., Caccuri A.M., Antonini G., Turella P., Stella L., Bello M.L., Federici G., and Ricci G. The specific interaction of dinitrosyl-diglutathionyl-iron complex, a natural NO carrier, with the glutathione transferase superfamily. Suggestion for an evolutionary pressure in the direction of the storage of nitric oxide. J. Biol. Chem. 278 (2003) 42283-42293
31. Levites Y., Amit T., Youdim M.B.H., and Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277 (2002) 30574-30580
32. L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells. J. Neurochem. 89 (2004) 124-133
33. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., and Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67 (1995) 631-647
34. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14 (2002) 381-395
35. Arendt T., Holzer M., Gartner U., and Bruckner M.K. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. J. Neural Transm., Suppl. 54 (1998) 147-158
36. Zambrano C.A., Egana J.T., Nunez M.T., Maccioni R.B., and Gonzalez-Billault C. Oxidative stress promotes τ dephosphorylation in neuronal cells: the roles of Cdk5 and PP1. Free Radical Biol. Med. 36 (2004) 1393-1402
37. Browne G.J., and Proud C.G. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269 (2002) 5360-5368
38. Garcia L., O'Loghlen A., Martin M.E., Burda J., and Salinas M. Does phosphorylation of eukaryotic elongation factor eEF2 regulate protein synthesis in ischemic preconditioning?. J. Neurosci. Res. 77 (2004) 292-298
39. Georgatos S.D., Stournaras C., and Blobel G. Heterotypic and homotypic associations between the nuclear lamins: site-specificity and control by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 4325-4329
40. Stone J.R., and Collins T. Rapid phosphorylation of heterogeneous nuclear ribonucleoprotein C1/C2 in response to physiologic levels of hydrogen peroxide in human endothelial cells. J. Biol. Chem. 277 (2002) 15621-15628
41. Kattapuram T., Yang S., Maki J.L., and Stone J.R. Protein kinase CK1α regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide. J. Biol. Chem. 280 (2005) 15340-15347